Back

Is all hypothyroidism in patients on amiodarone caused by the drug or is a some simply a consequence of the intensive monitoring of TSH in an at risk population?

20 March 2018 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 3 - Atrial fibrillation - Clinical Arrhythmias, General – Epidemiology, Prognosis, Outcome EHRA Premium Access EHRA 2018

About the speaker

Photo
Doctor Murray Matangi

Kingston Heart Clinic, Kingston (Canada)

39 More presentations in this session

Presentation thumbnail
Doctor R. De With (Groningen, NL)
Abstract
Presentation thumbnail
Doctor D. Ranganathan (Montreal, CA)
Abstract
Presentation thumbnail
Associate Professor M. Proietti (Milan, IT)
Abstract Slides
Presentation thumbnail
Professor N. Akoum (Seattle, US)
Abstract Slides
Presentation thumbnail
Doctor M. Vidal Burdeus (Barcelona, ES)
Abstract

Access the full session

Session thumbnail
Poster session 3 - Atrial fibrillation - Clinical

The Event

Event poster

EHRA 2018

20 March 2018 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources